News

Our mission Science for a Safer World remains at the heart of everything we do. Across our businesses, we provide the components, standards, and services that support scientific discovery, enable better health outcomes, and safeguard the integrity of food, medicines, and the environment.

The National Measurement Laboratory, Government Chemist and MHRA, three critical national functions of science and safety, brought together in a purpose-designed laboratory facility for the first time

Biosearch Technologies, signs MoU with Korea-based Genolution to integrate LGC’s sbeadex™ Lightning chemistry into the NX-Duo automated platform.

LGC Group opens its new Organic Chemistry Synthesis Centre of Excellence in Vaughan, Ontario, following a CAD $100 million investment.

LGC Group and Dynamic Devices announce their strategic partnership to enhance genomic solutions

LGC Board appoints Joydeep Goswami as President & Chief Executive

LGC’s leadership confirms that trading is in line with expectations, with positive momentum expected to continue through the second half of the year to 31 March 2025.

LGC acquires DiaMex to drive innovation and choice for core laboratory customers: Acquisition complements LGC’s serology and molecular quality control portfolio and enhances choice of products from a single supplier

LGC Biosearch Technologies launches Amp-Seq One: A revolutionary one-step targeted genotyping by sequencing workflow delivering speed and precision to enhance genomics in commercial breeding. Set to become the fastest amplicon sequencing protocol on the market, Amp-Seq One offers reduced hands-on time and doubled throughput for customers.

Holland & Barrett has inserted their mark on Informed Sport history, as they now hold the record as the company to certify the most products at the beginning of a partnership. With more than 60 product variances through their new and improved range of Precision Engineered Sports nutrition, Holland & Barrett has also become one of the largest ranges in the UK to be certified by Informed Sports.

LGC, a global leader in clinical diagnostics and genomics, announces a new strategic partnership with AccuGenomics, a pioneer in molecular diagnostic development. This collaboration is set to drive innovation in clinical diagnostic tools by combining LGC’s expertise in quality control solutions with AccuGenomics’ advanced next- generation sequencing (NGS) monitoring technologies.

LGC Clinical Diagnostics, a leader in quality solutions for molecular diagnostics, is delighted to announce the launch of the Seraseq® DPYD DNA Mutation Mix. This launch marks LGC Clinical Diagnostics’ entry into the rapidly expanding field of pharmacogenomics, furthering its commitment to personalized medicine. This cutting-edge reference material is designed for developing, validating, and routinely evaluating Next Generation Sequencing (NGS) assays and other molecular assays that detect critical mutations in the DPYD gene.